Medx Health Corp
TSXV:MDXView on OTC Pink - Current Information

  • LAST PRICE
    0.0550
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    0.0500/ 376
  • Ask / Lots
    0.0600/ 312
  • Open / Previous Close
    --- / 0.0550
  • Day Range
    ---
  • 52 Week Range
    0.0250
    0.1100
  • Volume
    ---

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

  • Oct 23, 2024

      Show headlines and story abstract

    • 10:24AM ET on Wednesday Oct 23, 2024 by Dow Jones
      Companies Mentioned: MDX

      MedX Health Corp. announces Amended Application for Series I Loan Note Extension
      MISSISSAUGA, Ontario--(BUSINESS WIRE)--October 23, 2024--
      MedX Health Corp. ("MedX" or the "Company") (TSX-V: MDX) announces that further to its Press Release dated August 6, 2024, the TSXV issued a Final Acceptance Letter dated August 14, 2024, in respect of the Amendment to the remaining outstanding $3,700,000 of the Series I Loan Notes issued in 2021, by the Extension of the Maturity Date from December 31, 2023, to December 31, 2025, but has since withdrawn that Final Acceptance. The Company is now filing an application for a revised Final Acceptance of the Extension of the Maturity Date for the Series I Loan Notes, only in respect of $2,650,000 of Series I Loan Notes in respect of which Extension Agreements have been signed. In the event that any of the holders of Series I Loan Notes who have not yet signed Extension Agreements do decide to accept the Extension, then the Company may submit request(s) to the TSXV for Acceptance, issuance of which will be subject to applicable TSXV Policies.

Peers Headlines